{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:22:01Z","timestamp":1779358921634,"version":"3.51.4"},"reference-count":28,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T00:00:00Z","timestamp":1376870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Research"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>The aim of this study was to elucidate the clinical and histological features, response to corticosteroid therapy and long\u2010term outcome of primary biliary cirrhosis (<jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content>) with features of autoimmune hepatitis (<jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Among 280 <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> patients under ursodeoxycholic acid administration, we identified 28 patients with <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content> features fulfilling the following criteria: sustained high levels of serum aminotransferases and high immunoglobulin <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content> levels with positivity for antinuclear antibodies or anti\u2010smooth muscle antibodies (<jats:styled-content style=\"fixed-case\">ASMA<\/jats:styled-content>) and\/or histological features of moderate to severe interface hepatitis or moderate to severe lobular hepatitis. We analyzed <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> patients with <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content> features, focusing mainly on therapeutic responses to corticosteroids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content> features included 26 women (93%). Their median age was 55 years, and the median follow\u2010up period was 7.5 years. Eight of these 28 patients were not actually treated with corticosteroids due to medical conditions. Among the 20 patients receiving corticosteroid therapy, 15 were responders and five were non\u2010responders. A high alkaline phosphatase (<jats:styled-content style=\"fixed-case\">ALP<\/jats:styled-content>) level, negativity for <jats:styled-content style=\"fixed-case\">ASMA<\/jats:styled-content> and positivity for gp210 were identified as risk factors for lack of a response to corticosteroid therapy. Among 28 <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> patients with <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content> features, the responders to corticosteroids had an excellent prognosis, while those who could not be treated with corticosteroids and non\u2010responders to corticosteroids had a poor outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content> features benefit from corticosteroid therapy. Features of <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> such as high <jats:styled-content style=\"fixed-case\">ALP<\/jats:styled-content> level, negativity for <jats:styled-content style=\"fixed-case\">ASMA<\/jats:styled-content> and positivity for gp210 appear to predict a poor response to corticosteroids.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hepr.12210","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T13:21:51Z","timestamp":1374672111000},"page":"947-955","source":"Crossref","is-referenced-by-count":27,"title":["Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy"],"prefix":"10.1111","volume":"44","author":[{"given":"Youko","family":"Yoshioka","sequence":"first","affiliation":[{"name":"Division of Internal Medicine Institute of Gastroenterology Tokyo Women's Medical University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Taniai","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine Institute of Gastroenterology Tokyo Women's Medical University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine Institute of Gastroenterology Tokyo Women's Medical University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Haruta","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine Institute of Gastroenterology Tokyo Women's Medical University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Shiratori","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine Institute of Gastroenterology Tokyo Women's Medical University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,8,19]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1068269"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-916322"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.23316"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.3368"},{"key":"e_1_2_5_6_1","first-page":"1135","volume-title":"Oxford Textbook of Clinical Hepatology","author":"Heathcote EJ","year":"1999"},{"key":"e_1_2_5_7_1","first-page":"336","article-title":"Nonsuppurative destructive chronic cholangitis and chronic hepatitis","volume":"3","author":"Popper H","year":"1970","journal-title":"Prog Liver Dis"},{"key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0016-5085(76)80453-2","article-title":"Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome","volume":"71","author":"Geubel AP","year":"1976","journal-title":"Gastroenterology"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.09.002"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180435"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00844.x"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.616"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280203"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005350300006"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.03.019"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1984.tb00914.x"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.050955"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.016"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280210"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.017"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06018.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03722.x"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21472"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00244.x"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-1"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.2957\/kanzo.40.454"}],"container-title":["Hepatology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhepr.12210","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hepr.12210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T13:36:16Z","timestamp":1696253776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hepr.12210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,19]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1111\/hepr.12210"],"URL":"https:\/\/doi.org\/10.1111\/hepr.12210","archive":["Portico"],"relation":{},"ISSN":["1386-6346","1872-034X"],"issn-type":[{"value":"1386-6346","type":"print"},{"value":"1872-034X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,19]]}}}